ArticleFrontiers in veterinary science2025
Efficiency of ultrasound-guided placental gene therapy in a rabbit IUGR model and effects on offspring development.
Article in Frontiers in veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Placental insufficiency is a major cause of intrauterine growth restriction (IUGR), and no effective prenatal therapy is currently available. Previous studies have demonstrated that gene therapies based on overexpression of insulin-like growth factor 1 (IGF-1) and vascular endothelial growth factor (VEGF) can improve prenatal and postnatal development. Such therapies are mostly adenovirus-mediated, since adenoviral vectors are the most widely used vehicles for gene delivery due to their broad cellular tropism, ability to transduce non-dividing cells, and relative easiness of production and titration. Hence, this study evaluated the feasibility and safety of a novel minimally invasive ultrasound-guided intraplacental technique for the injection of adenoviral vectors encoding IGF-1 or VEGF in a rabbit model of IUGR, in which the condition was induced by maternal feed restriction to 50% of the average daily intake during gestation. Postnatal development was assessed through biometric measurements (body weight), metabolic profiling (lipid, carbohydrate, and protein metabolism), and histological cell counts in key organs. The results confirmed the marker expression by adenoviral vectors in all the treated fetuses and the absence of deleterious effects of the ultrasound-guided injection on the postnatal survival and growth of the offspring. The use of the technique for inducing both IGF-1 and VEGF over-expression by administration of adenoviral vectors in an IUGR model showed, in the case of VEGF, positive effects on the developmental and metabolic traits, with especial significance in the pulmonary and intestinal systems, of IUGR offspring. Hence, after further research, the proposed therapy may offer potential benefits in pregnancies with placental insufficiency and IUGR conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.